Clinical trial
Evaluation of Serum Clusterin and Serum PTX3 Assay During Febrile Aplasia in Children Treated in Pediatric Oncology
NCT05584930 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Serum Clusterin and Serum PTX3 Assay During Febrile Aplasia in Children Treated in Pediatric Oncology
- Lead sponsor
- University Hospital, Angers
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 10, 2022
- Completion date
- August 6, 2024
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer childhood, febrile neutropenia